MedAlliance SELUTION DeNovo Study
Hospital Updates

MedAlliance Announces Enrollment of over 1,660 Patients in Landmark SELUTION DeNovo Study

MedAlliance has announced enrollment of over 1,660 patients in its ground-breaking SELUTION DeNovo coronary randomized study. Recruitment is now half way towards a planned 3,326 patients. SELUTION DeNovo compares the treatment strategy using a novel sirolimus drug-eluting balloon (SELUTION SLR), versus any limus drug-eluting stent (DES). SELUTION DeNovo is the largest DEB study ever initiated, […]